
Fulgent Genetics Investor Relations Material
Latest events

Q1 2025
Fulgent Genetics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Fulgent Genetics Inc
Access all reports
Segment Data
Access more data
Revenue by
Payor
Insurance
Institutional
Patient
Expenses by
Financials
Fulgent Genetics, Inc. provides clinical genetic testing services in the United States and internationally. It offers genetic testing services for various types of heredity conditions, such as intellectual disability and movement disorders; infectious diseases, including sexually transmitted infections; pharmacogenetic tests to help individuals determine drug sensitivities; oncology testing services focused on inherited cancer predisposition; prenatal genetic testing for genetic abnormalities; and pediatric and adult behavioral tests for attention deficit hyperactivity disorders. The company also provides COVID-19 testing kits to physicians. In addition, it offers development of customized multi-gene panels for clinical trial recruitment, which are designed for specific panels of genes associated with various genotypes or phenotypes; and PathFinderTG tool that evaluates the likelihood that a patient's symptoms could be caused by an underlying genetic condition. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Key slides for Fulgent Genetics Inc


Q2 2024
Fulgent Genetics Inc


Investor Presentation
Fulgent Genetics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
FLGT
Country
🇺🇸 United States